For Media Inquiries:
On Friday, July 24, the President signed four executive orders aimed at reducing prescription drug prices. While executive orders do not need congressional approval, each of these orders requires further rulemaking and are thus not immediately enforceable. In addition, all four orders will be fought in the courts by affected stakeholders and the orders could be withdrawn by a future administration. Nevertheless, if ever finalized, the orders could have a significant impact on drug costs in the future.
PBGH’s California Quality Collaborative hosted leading voices in health reform to address enhanced access to health care beyond the pandemic.
Read the statement.
On December 7, 2020, the Pacific Business Group on Health (PBGH) issued this statement regarding the announcement that President-elect Biden will nominate California Attorney General Xavier Becerra to serve as Secretary of the U.S. Department of Health and Human Services (HHS).
PBGH continues to closely monitor the federal legislative response to COVID-19 on behalf of our members. This statement outlines PBGH’s recommended policies so employers can continue to meet the health care needs of their employees and to deliver on PBGH’s core mission to improve the quality and affordability of the U.S. health care system.
PBGH is closely monitoring the federal legislative response to COVID-19 on behalf of our members. This policy statement outlines PBGH’s priorities and positions, which are focused on steps that will improve the quality and affordability of the U.S. health care system – the core elements of PBGH’s mission.
Read the letters distributed by the Pacific Business Group on Health to the members and staff of the House Education & […]
Read the statement issued by PBGH CEO Elizabeth Mitchell on the recently unveiled legislative text of the Consumer Protections Against Surprise Medical […]
PBGH partnered with Johns Hopkins University and Integrity Pharmaceutical Advisors (IPA) to disseminate a guide that includes tips for employers […]
PBGH applauds initiatives by Speaker Nancy Pelosi and other members of the House leadership to reduce prescription drug costs. Read […]
Elizabeth Mitchell sent a letter to the Senate HELP Committee on Tuesday, following her influential testimony at the Committee’s hearing on June 18. She continued to push for an end to surprise billing (including air ambulances), a reasonable benchmark for physician payments, reductions in drug costs, prohibitions on anti-competitive provider contracting terms, increased transparency (including for PBMs), and improvements in maternal and child health. The bill is under active consideration by the Committee, and a final version will be made public soon.